Expert Opinion On Investigational Drugs

期刊中文名：研究藥物專家意見(jiàn)ISSN：1354-3784E-ISSN：1744-7658

該雜志國(guó)際簡(jiǎn)稱：EXPERT OPIN INV DRUG，是由出版商Taylor and Francis Ltd.出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以PHARMACOLOGY & PHARMACY研究為重點(diǎn)，主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果，扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展，選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論，促進(jìn)學(xué)術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有很高的學(xué)術(shù)影響力。

基本信息：: 期刊簡(jiǎn)稱：EXPERT OPIN INV DRUG; 是否OA：未開(kāi)放; 是否預(yù)警：否; Gold OA文章占比：11.27%

出版信息：: 出版地區(qū)：ENGLAND; 出版周期：Monthly; 出版語(yǔ)言：English; 出版商：Taylor and Francis Ltd.

評(píng)價(jià)信息：: 中科院分區(qū)：2區(qū); JCR分區(qū)：Q1; 影響因子：4.9; CiteScore：10

投稿咨詢加急咨詢

雜志介紹中科院JCR分區(qū) JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Expert Opinion On Investigational Drugs雜志介紹

《Expert Opinion On Investigational Drugs》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱研究藥物專家意見(jiàn)，本刊主要出版、報(bào)道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為4.9，最新CiteScore 指數(shù)為10。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
Author: Zhang, Junmin; Zhang, Juanhong; Leung, Elaine Lai-Han; Yao, Xiao-Jun
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study
Author: Yan, Diqin; Niu, Suping; Hu, Dingyuan; Dong, Wenliang; Sun, Yunjuan; Wang, Qian; Wang, Simin; Gu, Qun; Liu, Gang; Wang, Jiaxue; Chen, Liming; Lv, Jie; Zheng, Qingshan; Song, Haifeng; Fang, Yi
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects
Author: Wang, Yanli; Xue, Jinling; Su, Zhengjie; Cui, Yingzi; Liu, Guangwen; Yang, Wei; Liu, Zhengzhi; Chen, Jiahui; Ren, Qing; Yu, Shuang; Cheng, Yang; Zhou, Yannan; Wang, Wanhua; Chen, Xuesong; Qu, Dongmei; Deng, Qiaohuan; Zhao, Yicheng; Yang, Haimiao
The Jakinibs in systemic lupus erythematosus: progress and prospects.
Author: Mok CC¹.

英文介紹

Expert Opinion On Investigational Drugs雜志英文介紹

Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.

The Editors welcome:

Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies

Drug Evaluations reviewing the clinical and pharmacological data on a particular drug

Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials

The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.

中科院SCI分區(qū)

Expert Opinion On Investigational Drugs雜志中科院分區(qū)信息

2023年12月升級(jí)版

綜述：是

TOP期刊：否

大類：醫(yī)學(xué) 2區(qū)

小類：